ARCHIVES

Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

Maggie’s Bill Pays Off; NCI Celebrates 40th

August 12, 1977

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009